Viemed Healthcare (VMD) Stock Price, News & Analysis

Company Overview

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Key Stats

• Today's Range: $6.66 to $7.13
• 50-Day Range: $5.93 to $7.17
• 52-Week Range: $5.93 to $9.81
• Volume: 486,325 shs
• Average Volume: 270,100 shs
• Market Capitalization: $275.06 million
• P/E Ratio: 20.47
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Viemed Healthcare Stock Analysis - MarketRank™

Viemed Healthcare scored higher than 56% of companies evaluated by MarketBeat, and ranked 407th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Viemed Healthcare.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Viemed Healthcare is 20.47, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.81.

Price to Earnings Ratio vs. Sector

The P/E ratio of Viemed Healthcare is 20.47, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.88.

Price to Book Value per Share Ratio

Viemed Healthcare has a P/B Ratio of 2.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.18% of the float of Viemed Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Viemed Healthcare has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Viemed Healthcare has recently decreased by 87.36%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Viemed Healthcare does not currently pay a dividend.

Dividend Growth

Viemed Healthcare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.18% of the float of Viemed Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Viemed Healthcare has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Viemed Healthcare has recently decreased by 87.36%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.59

News Sentiment

Viemed Healthcare has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Viemed Healthcare this week, compared to 1 article on an average week.

MarketBeat Follows

Only 2 people have added Viemed Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Viemed Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $301,005.00 in company stock.

Percentage Held by Insiders

20.00% of the stock of Viemed Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

74.24% of the stock of Viemed Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

VMD Stock Analysis - Frequently Asked Questions

How have VMD shares performed this year?

Viemed Healthcare's stock was trading at $8.02 at the start of the year. Since then, VMD shares have decreased by 13.2% and is now trading at $6.96.

How were Viemed Healthcare's earnings last quarter?

Viemed Healthcare, Inc. (NASDAQ:VMD) posted its quarterly earnings results on Wednesday, August, 6th. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by $0.01. The business earned $63.06 million during the quarter, compared to analysts' expectations of $63.50 million. Viemed Healthcare had a trailing twelve-month return on equity of 10.56% and a net margin of 5.80%.
Read the conference call transcript.

Who are Viemed Healthcare's major shareholders?

Top institutional investors of Viemed Healthcare include First Eagle Investment Management LLC (1.15%), Penbrook Management LLC (0.46%), AMH Equity Ltd (0.20%) and Campbell & CO Investment Adviser LLC (0.17%). Insiders that own company stock include Nitin Kaushal, Randy E Dobbs, Timothy Smokoff and Sabrina Heltz.
View institutional ownership trends.

How do I buy shares of Viemed Healthcare?

Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Viemed Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Viemed Healthcare investors own include Myomo (MYO), Cassava Sciences (SAVA), Alpha Teknova (TKNO), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Zevra Therapeutics (ZVRA) and Enterprise Products Partners (EPD).

Company Calendar

• Last Earnings: 8/06/2025
• Today: 8/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:VMD
• CIK: 1729149
• Web: www.viemed.com
• Phone: (337) 504-3802
• Fax: N/A
• Employees: 1,179
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.34
• Trailing P/E Ratio: 20.47
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $11.27 million
• Net Margins: 5.80%
• Pretax Margin: 7.61%
• Return on Equity: 10.56%
• Return on Assets: 7.99%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 1.38
• Quick Ratio: 1.26

Sales & Book Value

• Annual Sales: $224.26 million
• Price / Sales: 1.23
• Cash Flow: $1.01 per share
• Price / Cash Flow: 6.86
• Book Value: $3.41 per share
• Price / Book: 2.04

Miscellaneous

• Outstanding Shares: 39,520,000
• Free Float: 31,619,000
• Market Cap: $275.06 million
• Optionable: Not Optionable
• Beta: 1.33